Arena Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 76   

Articles published

ARNA 4.73 -0.04 (-0.84%)
price chart
Arena Pharmaceuticals Inc. Still Down After CEO's Sale
"Week-over-week prescriptions are increasing. We're very excited about that. And we expect those prescriptions to continue to increase as, yet a larger salesforce, goes into the field in the next few weeks.
Special News: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Exelixis, Inc ...
Lakeway, NY - (MARKET NEWS CALL) - 7/31/2014� Specialpennystockalert.com, an investment community with a special focus on updating investors with recent news on the U.S.
Notable Movers: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), EnteroMedics ...  Techsonian (press release)
Abnormal Stocks' Move- The Goodyear Tire & Rubber (NASDAQ:GT ...  eMarketsDaily
Related articles »  
Eisai and Arena Pharmaceuticals Announce BELVIQ(R) (lorcaserin HCl) CIV ...
WOODCLIFF LAKE, N.J. and SAN DIEGO, July 29, 2014 /PRNewswire/ -- Eisai Inc. and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that BELVIQ(R) (lorcaserin HCl) has been nominated by the Galien Foundation and Awards Committee ...
Related articles »  
Most Active Buzz: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Oi SA (NYSE ...
Lakeway, NY - (MARKET NEWS CALL) - 7/29/2014� Specialpennystockalert.com, an investment community with a special focus on updating investors with recent news on the U.S.
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Sells Marketing And Distribution ...
Dallas, Texas 07/22/2014 (ustradevoice) - Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)'s wholly owned subsidiary Arena Pharmaceuticals GmbH has undertaken a marketing and supply deal for BELVIQ� with Abic Marketing Limited, the local Israel-based ...
Arena Pharmaceuticals Enters into Marketing and Supply Agreement for BELVIQ ...  Wall Street Journal
Teva's subsidiary, Abic to market Arena Pharma's Belviq in Israel  pharmabiz.com
Related articles »  
Why Arena Pharmaceuticals (ARNA) Stock Is Dropping Today
NEW YORK (TheStreet) -- Arena Pharmaceuticals (ARNA_) shares are plummeting, down -8.1% to $5.37, on Monday after CEO Jack Lief sold 223,525 shares of the company at an average price $5.85 for a total transaction of $1,307,621.25, according to an ...
Arena chief's stock sale invites criticism (ARNA)  Seeking Alpha
Arena Stock Takes A Tumble � CEO Sells Shares, Investor Confidence Falls  Bidness Etc
Related articles »  
Arena Pharmaceuticals to Host Corporate Update and Financial Results ...
SAN DIEGO, July 25, 2014 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) today announced that it will provide a corporate update and report second quarter 2014 financial results before the NASDAQ Global Select Market opens on Friday, ...
Related articles »  
Active Watch List : Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Amazon.com ...
Arena Pharmaceuticals (NASDAQ:ARNA) CEO Jack Lief sold 223,525 shares of Arena Pharmaceuticals stock in a transaction dated Tuesday, July 1st.
News Recap: Amicus Therapeutics, Inc. (NASDAQ:FOLD), Arena ...  Market News Call
Hot Stock List: Arena Pharmaceuticals (NASDAQ:ARNA), Glu Mobile Inc ...  Crazy Joys
Related articles »  
Morning Buzz -American Apparel Inc (APP), Arena Pharmaceuticals, Inc. (ARNA ...
Stamford, Connecticut �28h June 2014- (Techsonian) - American Apparel Inc (NYSEMKT:APP) announced it has reached a Nomination, Standstill and Support Agreement with Standard General L.P.
Related articles »  
Stocks to Keep Your Eyes on-Arena Pharmaceuticals, Inc. (NASDAQ:ARNA ...
Las Vegas, NV - July 28, 2014 - (Tech Sonian) �Arena Pharmaceuticals, Inc. (ARNA) reported that its wholly owned subsidiary, Arena Pharmaceuticals GmbH, has entered into an exclusive marketing and supply agreement for BELVIQ� (lorcaserinHCl) with ...
Related articles »